This week’s news has been dominated by the downfall of ‘rock star’ investment manager Neil Woodford, who has made his name by championing many businesses in UK biotech.
Drug development can be quite a risky business at the best of times, but particularly in the biotech sector where companies may only have a few assets to their name.